Yayın:
Clinical Trials in Underdeveloped Countries and Ethical Violations: the Nigerian Case of a Phase III Antibiotic Trial

Sadeleştirilmiş öğe sayfası
dc.contributor.authorTemel, Mustafa
dc.contributor.orcid0000-0003-0828-0660
dc.date.accessioned2025-11-13T22:53:34Z
dc.date.issued2017-09-22
dc.identifier.doihttps://doi.org/10.21673/anadoluklin.336697
dc.identifier.issn2149-5254
dc.identifier.openalexW2758354769
dc.identifier.urihttps://hdl.handle.net/11421/15652
dc.identifier.urihttps://doi.org/10.21673/anadoluklin.336697
dc.language.isoen
dc.relation.ispartofAnadolu Kliniği Tıp Bilimleri Dergisi
dc.rightsopenAccess
dc.subjectGovernment (linguistics)
dc.subjectDeclaration
dc.subjectDouble standard
dc.subjectClinical trial
dc.subjectDeclaration of Helsinki
dc.subjectConvention
dc.subjectInformed consent
dc.subjectLaw
dc.subjectPolitical science
dc.subjectMedicine
dc.subjectFamily medicine
dc.subjectPediatrics
dc.subjectAlternative medicine
dc.subjectPathology
dc.subject.sdg16
dc.titleClinical Trials in Underdeveloped Countries and Ethical Violations: the Nigerian Case of a Phase III Antibiotic Trial
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5082817491

Dosyalar

Koleksiyonlar

Publications